Equity

Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

Abbott Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively decreased by 0.7% to $25.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from $25.13B to $25.35B. Over 5 years (FY 2020 to FY 2025), Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively shows relatively stable performance with a 1.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 29, 2026

How to read this metric

Changes are typically driven by stock issuances or share cancellations rather than operational performance.

Detailed definition

This represents the par value of the common shares issued and outstanding. It is a fundamental component of shareholders...

Peer comparison

Standard accounting line item; usually remains stable unless there is a significant equity financing event.

Metric ID: equity_common_stock_value

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$24.15B$24.29B$24.47B$24.30B$24.43B$24.56B$24.71B$24.49B$24.61B$24.73B$24.87B$24.73B$24.86B$25.02B$25.15B$25.13B$25.28B$25.41B$25.53B$25.35B
QoQ Change+0.5%+0.8%-0.7%+0.5%+0.5%+0.6%-0.9%+0.5%+0.5%+0.6%-0.6%+0.5%+0.7%+0.5%-0.1%+0.6%+0.5%+0.5%-0.7%
YoY Change+1.1%+1.1%+1.0%+0.8%+0.7%+0.7%+0.6%+1.0%+1.0%+1.2%+1.1%+1.6%+1.7%+1.6%+1.5%+0.9%
Range$24.15B$25.53B
CAGR+1.0%
Avg YoY Growth+1.1%
Median YoY Growth+1.1%

Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively at Other Companies

Frequently Asked Questions

What is Abbott's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
Abbott (ABT) reported common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively of $25.35B in Q1 2026.
How has Abbott's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively changed year-over-year?
Abbott's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively increased by 0.9% year-over-year, from $25.13B to $25.35B.
What is the long-term trend for Abbott's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively?
Over 5 years (2020 to 2025), Abbott's common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively has grown at a 1.1% compound annual growth rate (CAGR), from $24.15B to $25.53B.
What does common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively mean?
The nominal par value of all common shares issued by the company.